Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases

International Journal of Gynecological Cancer

Volumn 13, Issue 6, 2003, Pages 879-888

  Xue, W C ^a   Feng, H C ^a   Tsao, S W ^a   Chan, K Y K ^a   Ngan, H Y S ^a   Chiu, P M ^a   Maccalman, C D ^b   Cheung, A N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cadherin 11; E cadherin; Gestational trophoblastic diseases; Hydatidiform mole; Methylation

Indexed keywords

CADHERIN; CADHERIN 11; COMPLEMENTARY DNA; RNA; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CHORIOCARCINOMA; CLINICAL ARTICLE; DNA METHYLATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; INDUCED ABORTION; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLASTIC TUMOR; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CADHERINS; CHORIOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; METHYLATION; PLACENTA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERINE NEOPLASMS;

EID: 1242277423     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2003.13400.x     Document Type: Article

References (47)

1. Suzuki S, Sano K, Tanihara H. Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. Cell Regul 1991;2:261-70.
2. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-5.
3. Tanihara H, Kido M, Obata S et al. Characterization of cadherin-4 and cadherin-5 reveals new aspects of cadherins. J Cell Sci 1994;107:1697-704.
4. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995;7:619-27.
5. Geiger B, Ayalon O. Cadherins. Ann Rev Cell Biol 1992;8:307-32.
6. Grunwald GB. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 1993;5:797-805.
7. Okazaki M, Takeshita S, Kawai S et al. Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem 1994;269:12092-8.
8. Kimura Y, Matsunami H, Inoue T et al. Cadherin-11 expressed in association with mesenchymal morphogenesis in the head, somite, and limb bud of early mouse embryos. Dev Biol 1995;169:347-58.
9. Zhou R, Skalli O. Identification of cadherin-11 down-regulation as a common response of astrocytoma cells to transforming growth factor-alpha. Differentiation 2000;66:165-72.
10. MacCalman CD, Furth EE, Omigbodun A, Bronner M, Coutifaris C, Strauss JF 3rd. Regulated expression of cadherin-11 in human epithelial cells: a role for cadherin-11 in trophoblast-endometrium interactions? Dev Dyn 1996;206:201-11.
11. Babawale MO, Van Noorden S, Pignatelli M, Stamp GW, Elder MG, Sullivan MH. Morphological interactions of human first trimester placental villi co-cultured with decidual explants. Hum Reprod 1996;11:444-50.
12. Zhou Y, Fisher SJ, Janatpour M et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997;99:2139-51.
13. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997;99:2152-64.
14. Getsios S, Chen GT, Huang DT, MacCalman CD. Regulated expression of cadherin-11 in human extravillous cytotrophoblasts undergoing aggregation and fusion in response to transforming growth factor beta 1. J Reprod Fertil 1998;114:357-63.
15. MacCalman CD, Getsios S, Chen GT. Type 2 cadherins in the human endometrium and placenta, their putative roles in human implantation and placentation. Am J Reprod Immunol 1998;39:96-107.
16. Mazur MT, Kurman RJ. Gestational trophoblastic disease. In: Kurman, RJ, ed. Blaustein's Pathology of the Female Genital Tract, 4th Edition. New York: Springer-Verlag 1994: 1049-93.
17. Elston CW. Gestational trophoblastic disease. In Fox H, ed. Haines and Taylor Obstetrical and Gynaecological Pathology, 4th edn. New York: Churchill Livingstone, 1995: 1597-640.
18. Wong SY, Ngan HY, Chan CC, Cheung ANY. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Mod Pathol 1999;12:1025-33.
19. Chiu PM, Ngan YS, Khoo US, Cheung ANY. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology 2001;38:243-9.
20. Cheung ANY, Zhang DK, Ngan YS, Shen DH, Tsao SW. Telomerase activity in gestational trophoblastic disease. J Clin Pathol 1999;52:588-92.
21. Vegh GL, Tuncer ZS, Fulop V, Genest DR, Mok SC, Berkowitz RS. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol Oncol 1999;75:248-53.
22. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 1999;59:947-52.
23. Tomita K, van Bokhoven A, van Leenders GJ et al. Cadherin switching in human prostate cancer progression. Cancer Res 2000;60:3650-4.
24. Schulz S, Becker KF, Braungart E et al. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours. J Pathol 2000;191:162-9.
25. Graff JR, Herman JG, Lapidus RG et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995;55:5195-9.
26. Vos CB, Cleton-Jansen AM, Berx G et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997;76:1131-3.
27. Leung WK, Yu J, Ng EK et al. Concurrent hypermethylation of multiple tumour-related genes in gastric carcinoma and adjacent normal tissues. Cancer 2001;91:2294-301.
28. Charpin C, Garcia S, Bouvier C et al. E-cadherin quantitative immunocytochemical assays in breast carcinomas. J Pathol 1997;181:294-300.
29. Bankfalvi A, Terpe HJ, Breukelmann D et al. Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology 1999;34:25-34.
30. Kashima T, Kawaguchi J, Takeshita S et al. Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis. Am J Pathol 1999; 155:1549-55.
31. Li HW, Cheung AN, Tsao SW, Cheung AL, O WS. Expression of e-cadherin 0ald Beta-catenin in trophoblastic tissue in normal and pathological pregnancies. Int J Gynecol Pathol 2003;22:63-70.
32. Ma HK, Wong LC, Ngan HY. The modern management of trophoblastic disease. In: Bonnar, J, ed. Recent Advances in Obstetrics and Gynaecology. Edinburgh: Churchill Livingstone 1990: 3-23.
33. Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 2001;159:831-5.
34. Tsao SW, Liu Y, Wang X et al. The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. Eur J Cancer 2003;39:524-31.
35. Bussemakers MJ, Van Bokhoven A, Tomita K, Jansen CF, Schalken JA. Complex cadherin expression in human prostate cancer cells. Int J Cancer 2000;85:446-50.
36. Chan KY, Ozcelik H, Cheung AN, Ngan HY, Khoo US. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res 2002;62: 4151-6.
37. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
38. Chen GT, Getsios S, MacCalman CD. Cadherin-11 is a hormonally regulated cellular marker of decidualization in human endometrial stromal cells. Mol Reprod Dev 1999;52:158-65.
39. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333-9.
40. Zheng Z, Pan J, Chu B, Wong YC, Cheung AL, Tsao SW. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol 1999;30:458-66.
41. Poser I, Dominguez D, de Herreros AG, Varnai A, Buettner R, Bosserhoff AK. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 2001;276: 24661-6.
42. Swami S, Kumble S, Triadafilopoulos G. E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am J Gastroenterol 1995;90:1808-13.
43. de Boer CJ, van Dorst E, van Krieken H et al. Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am J Pathol 1999;155:505-15.
44. Shih IM, Kurman RJ. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease. Verh Dtsch Ges Pathol 1997;81:266-72.
45. Floridon C, Nielsen O, Holund B et al. Localization of E-cadherin in villous, extravillous and vascular trophoblasts during intrauterine, ectopic and molar pregnancy. Mol Hum Reprod 2000;6:943-50.
46. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5′-CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000;275:2727-32.
47. Chang HW, Chow V, Lam KY, Wei WI, Yuen AP. Loss of E-cadherin expression resulting from promoter hyper-methylation in oral tongue carcinoma and its prognostic significance. Cancer 2002;94:386-92.